Evidence map›Paper›PMID 33621233›Full record

ArticlePLoS neglected tropical diseases2021

In pursuit of a cure: The plural therapeutic landscape of onchocerciasis-associated epilepsy in Cameroon - A mixed methods study.

Maya Ronse, Julia Irani, Charlotte Gryseels, Tom Smekens, Serge Ekukole, Caroline Teh Monteh, Peter Tatah Ntaimah, Susan Dierickx, Kristien Verdonck, Robert Colebunders and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Maya RonseDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0001-7182-6940
Julia IraniDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-0224-1794
Charlotte GryseelsDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-8963-4469
Tom SmekensDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-3599-1719
Serge EkukoleDepartment of Internal Medicine (Neurology Unit), Faculty of Medicine and Biomedical Science, University of Yaoundé I, Yaoundé, Cameroon.
Caroline Teh MontehDepartment of Internal Medicine (Neurology Unit), Faculty of Medicine and Biomedical Science, University of Yaoundé I, Yaoundé, Cameroon.
Peter Tatah NtaimahDepartment of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, Buea, Cameroon.
Susan DierickxCentre of Expertise on Gender, Diversity and Intersectionality (RHEA), Vrije Universiteit Brussel, Brussels, Belgium.
Kristien VerdonckDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0003-1153-4078
Robert ColebundersGlobal Health Institute, University of Antwerp, Antwerp, Belgium.ORCID 0000-0002-1919-1340
Alfred K NjamnshiDepartment of Internal Medicine (Neurology Unit), Faculty of Medicine and Biomedical Science, University of Yaoundé I, Yaoundé, Cameroon.ORCID 0000-0003-0052-1511
Sarah O'NeillDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Koen Peeters GrietensDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0001-6570-9887
Instituut voor Tropische Geneeskunde · BEUniversité de Yaoundé I · CMUniversité Libre de Bruxelles · BEUniversity of Antwerp · BEUniversity of Buea · CMVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA high prevalence of epilepsy has been observed in several onchocerciasis-endemic villages in the Sanaga River basin, Cameroon. Recent studies suggest that ivermectin, a drug that is distributed annually with the aim of eliminating onchocerciasis, may have a protective effect against acquiring onchocerciasis-associated epilepsy (OAE). This study, therefore, provides an in-depth understanding of both the complex therapeutic landscape for epilepsy as well as the experiences related to the 'community-directed treatment with ivermectin' (CDTI) campaign in order to identify a more trenchant path forward in the fight against epilepsy. METHODOLOGY/PRINCIPAL

findingsBased on a mixed methods study combining a qualitative strand with a quantitative survey, we found that epilepsy was perceived to have had an epidemic emergence in the past and was still considered an important health issue in the study area. Socio-economic status, availability and accessibility of drugs and practitioners, as well as perceived aetiology shaped therapeutic itineraries for epilepsy, which included frequenting (in)formal biomedical health care providers, indigenous and/or faith healing practitioners. Ivermectin uptake for onchocerciasis was generally well known and well regarded. The CDTI faced structural and logistical bottlenecks undermining equal access and optimal adherence to the drug. CONCLUSIONS/SIGNIFICANCE: Locally accessible, uninterrupted, sustainable and comprehensive health-service delivery is essential to help alleviate the epilepsy burden on afflicted households. Addressing structural challenges of CDTI and communicating the potential link with epilepsy to local populations at risk could optimize the uptake of this potentially significant tool in OAE prevention.

Indexed as

AdultCameroonCross-Sectional StudiesEpilepsyFemaleHumansIvermectinMaleMiddle AgedOnchocerciasisPrevalenceSocioeconomic FactorsSurveys and QuestionnairesIvermectin

Identifiers

PMID33621233
PMCPMC7946181
OpenAlexW3132688787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.